Page 134 - CSIR-IGIB Annual Report 2020-21
P. 134
Sivaprakash Ramalingam
Our lab is interested in studying basic biology of rare genetic disorders
prevalent in the Indian subcontinent and developing curative cell and gene
therapies for blood disorders and hematological malignancies using two
breakthrough technologies: stem cell engineering and site-specific genome-
editing.
Annual Report 2020-21 131
